Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency

American Journal of Cardiology

Volumn 77, Issue 1, 1996, Pages 31-36

  Eritsland, Jan ^a   Arnesen, Harald ^a   Grønseth, Knut ^a   Fjeld, Nils B ^a   Abdelnoor, Michael ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; FEMALE; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030066624     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89130-8     Document Type: Article

References (30)

1. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 318:549-557.
2. Weiner BH, Ockene IS, Levine PH, Cuenoud HF, Fisher M, Johnson BF, Daoud AS, Jarmolych J, Hosmer D, Johnson MH, Natale A, Vaudreuil C, Hoogasian JJ. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med 1986;315:841-846.
3. Landymore RW, Manku MS, Tan M, MacAulay MA, Sheridan B. Effects of low-dose marine oils on intimai hyperplasia in autologous vein grafts. J Thorac Cardiovasc Surg 1989;98:788-791.
4. Sarris GE, Fann JI, Sokoloff MH, Smith DL, Loveday M, Kosek JC, Stephens RJ, Cooper AD, May K, Willis AL, Miller DC. Mechanisms responsible for inhibition of vein-graft arteriosclerosis by fish oil. Circulation 1989;80(suppl I):I-109-I-123.
5. Henderson WG, Goldman S, Copeland JG, Moritz TE, Harker LA. Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. Ann Intern Med 1989;111:743-750.
6. Fremes SE, Levinton C, Naylor CD, Chen E, Christakis GT, Goldman BS. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. Eur J Cardiothorac Surg 1993;7:169-180.
7. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991;34:45-68.
8. Bourassa MG, Campeau L, Lespérance J, Grondin CM. Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography. Circulation 1982;65(suppl II):II-90-II-97.
9. Nes M, Frost Andersen L, Solvoll K, Sandstad B, Hustvedt BE, Lovo A, Drevon CA. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women. Eur J Clin Nutr 1992;46:809-821.
10. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23:882-884.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 1972;18:499-502.
12. Arnesen H, Semb G, Hol R, Karlsen H. Fibrinolytic capacity after venous stasis in patients undergoing aorto-coronary by-pass surgery. Relation to shunt occlusion. Scand J Haematol 1983;30(suppl 39):43-46.
13. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
14. Epi Info. Version 5.01a. Atlanta, GA: Centers for Disease Control Epidemiology Program Office, 1991.
15. Verstraete M, Brown BG, Chesebro JH, Ekeström S, Harker LA, Henderson AH, Jewitt DE, Oliver MF, Sleight P. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J 1986;7:4-13.
16. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LAR, Gill GC, Taylor PC, Sheldon WC, Proudfit WL. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6.
17. Harker LA, Kelly AB, Hanson SR, Krupski W, Bass A, Osterud B, FitzGerald GA, Goodnight SH, Connor WE. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 1993;87:1017-1029.
18. 3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 1984;307:165-168.
19. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217-1224.
20. Knapp HR, Reilly IAG, Alessandrini P, FitzGerald GA. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986;314:937-942.
21. DeCaterina R, Giannessi D, Mazzone A, Bernini W, Lazzerini G, Maffei S, Cerri M, Salvatore L, Weksler B. Vascular prostacyclin is increased in patients ingesting ω-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation 1990;82:428-438.
22. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JWM, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer EJ, Wolff SM, Dinarello CA. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-271.
23. Fox PL, DiCorletto PE. Fish oils inhibit endothelial production of platelet-derived growth factor-like protein. Science 1988;241:453-456.
24. Shimokawa H, Vanhoutte PM. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988;78:1421-1430.
25. Lehr H-A, Hübner C, Finckh B, Nolte D, Beisiegel U, Kohlschütter A, Messmer K. Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein. Circulation 1991;84:1725-1731.
26. Berg Schmidt E, Pedersen JO, Varming K, Ernst E, Jersild C, Grunnet N, Dyerberg J. n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. Arterioscler Thromb 1991;11:429-435.
27. Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch Intern Med 1993;153:1595-1601.
28. Leaf A, Jorgensen MB, Jacobs AK, Cote G, Schoenfeld DA, Scheer J, Weiner BH, Slack JD, Kellert MA, Raizner AE, Weber PC, Mahrer PR, Rossouw JE. Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994;90: 2248-2257.
29. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79: 1374-1387.
30. van der Meer J, Hillege HL, Koostra GJ, Ascoop CAPL, Pfisterer M, van Gilst WH, Lie KI. Prevention of one-year vein graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. Lancet 1993;342:257-264.